Eizen Joshua M
Insider trades filed on SEC Form 4, newest first. SEC CIK 0001949621.
- 13
- Form 4 lines on record
- 0
- Purchases (code P)
- 6
- Sales (code S)
- Nov 6, 2026, 7:20 PM ET
- Latest filing
Companies Eizen Joshua M reports for
- AN2 Therapeutics, Inc. ANTX, Chief Operating Officer and Chief Legal OfficerLast filed Nov 6, 2026, 6:20 PM ET
Holdings
LockedShares owned after each company's most recent Form 4, valued at the current price. Part of InsiderScanner.
- Filed Nov 6, 2026, 6:20 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jul 10, 2026, 6:15 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Mar 23, 2026, 7:06 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Mar 23, 2026, 7:06 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Feb 23, 2026, 4:41 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jan 7, 2026, 8:12 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jan 7, 2026, 8:12 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Nov 6, 2025, 6:12 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Feb 28, 2025, 4:22 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jan 7, 2025, 7:57 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Nov 5, 2024, 4:51 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
Shares, price, value, trade date and holdings after the trade are locked on 13 rows here. Included with InsiderScanner ($9.99 a month) and Signal8 Pro.
Unlock with InsiderScanner